Cargando…
ALL-083 ALLogeneic Hematopoietic Stem Cell Transplantation of a R/R T-ALL Patient Given Nelarabine, 3 Weeks Post Moderate COVID-19 Infection in the Local Setting
The COVID-19 pandemic has been a trying period, with an increased risk of infections and post-disease complications in patients with leukemia, particularly transplant candidates. Not enough studies have shown the effects of doing HSCT in recently treated COVID patients, nor the appropriate interval...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489253/ http://dx.doi.org/10.1016/S2152-2650(22)01181-8 |